NEI Research News

A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy.

New generation CRISPR technology lays foundation for therapeutics to treat a wide range of inherited ocular diseases

Researchers from Florida Atlantic University’s Schmidt College of Medicine hope to conquer a major limitation in the ability for scientists to engineer tissues for regenerative therapies for age-related and degenerative diseases.

The National Eye Institute (NEI) Audacious Goals Initiative (AGI) is exploring the possibility that the natural world holds the keys to restorative therapies that might unlock regenerative powers in humans.

Researchers at the UC Davis Department of Biomedical Engineering have come up a with a new, rapid method for characterizing and calibrating spectrometers, based on how they respond to noise.

A treatment that uses immune system T-cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with tissue from a human eye cancer known as retinoblastoma.

Salk scientists discover patterns of neural waves in the awake brain that help detect objects.

Oklahoma Medical Research Foundation scientists have identified a compound that could give birth to therapies for a host of eye diseases that include retinopathy of prematurity and diabetic retinopathy.

A team of researchers has identified networks of genes that allow neurons to regenerate in animals like zebrafish.

NEI-funded scientists are hacking the zebrafish’s innate regenerative capacity to learn how to treat human disease.